Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash

Boston Scientific expects 8-10% sales growth in their 2024-2026 guidance, which already includes short-term upsides such as FARAPULSE’s recent FDA approval. The legal clash between Axonics and ... Read More

‘Boston, we have a problem’: More high schoolers are feeling hopeless, new report says

Released Wednesday, the report focuses on mental ... and hospital data. Among the more alarming findings: About 44% of Boston’s public high school students said they felt sad or hopeless every ... Read More

College student in Boston hospitalized with meningitis, reports say

according to local reports. The college sent out a notice about the hospitalization to the community Wednesday, NBC Boston reported. A spokesperson confirmed that a student had the infection but ... Read More

Boston Scientific: The Market's Newest Mega-Cap Needs A Breather

Boston Scientific has rallied nearly 40% over the past year, driving its market value to a milestone of $100 billion for the first time. We preview BSX's upcoming Q1 earnings report set to be ... Read More

New Report Shows Data on Positive Truck Driver Drug Tests

The news outlet Transport Topics discussed the newest data from the report. The article points out that the one thing that hasn’t changed is that drivers who previously tested positive for one ... Read More

Roivant, Priovant report positive data from non-infectious uveitis trial

Roivant and Priovant Therapeutics have announced positive outcomes from the Phase II NEPTUNE clinical trial of brepocitinib in non-anterior non-infectious uveitis (NIU). The double-blind trial ... Read More

Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst

Shockwave Medical reportedly sought bids around the mid-$300s per share, Piper notes, citing a StreetInsider report. Both Medtronic and Boston Scientific had shown previous interest in acquiring ... Read More

Boston Scientific Corp BSX

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ... Read More

Boston Scientific Says FTC Issues Second Request Amid Boston Scientific And Axonics Merge Review

(RTTNews) - Boston Scientific Corp. (BSX) revealed Thursday in a Form 8-K filing with the U.S. Securities and Exchange Commission that the company and Axonics each received a request for ... Read More

Inozyme Reports Positive Topline Data From Phase 1/2 Study Of INZ-701; Stock Up

(RTTNews) - Inozyme Pharma, Inc. (INZY) Monday reported positive topline data from ongoing Phase 1/2 study of its drug candidate INZ-701 in adults with ABCC6 Deficiency (PXE, pseudoxanthoma ... Read More

Boston Scientific (NYSE: BSX)

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and ... Read More